Breaking News Instant updates and real-time market news.

APEN

Apollo Endosurgery

$4.20

-1.46 (-25.80%)

05:43
08/11/17
08/11
05:43
08/11/17
05:43

Apollo Endosurgery provides update, clarity to FDA letter to providers

Apollo Endosurgery provided an update and clarifications to a letter the FDA sent to Health Care Providers dated August 10, 2017 relating to potential risks with liquid-filled intragastric balloons, including the company's ORBERA intragastric balloon system. In relation to the ORBERA balloon, the facts are: ORBERA is approved by the FDA as safe and effective in assisting adult patients suffering from obesity with a body mass index of 30 to 40 in losing and maintaining weight. There have been five reported deaths of patients who had received the ORBERA intragastric balloon in four different countries since ORBERA's FDA approval in August of 2015. Apollo self-reported all five cases to the FDA as part of its Global Product Surveillance program. The FDA's letter to Health Care Providers does not indicate that the patient deaths were related to the ORBERA device or the insertion procedures. While the cause of death has not been provided or determined in all cases, Apollo has not received any communication or indication from the attending physicians or hospitals that the deaths have been due to the ORBERA device. Apollo has received no product liability-related claims in connection with these five cases. As stated in the ORBERA Directions For Use, in the period from January 1, 2006 through March 31, 2017, there have been 21 reported deaths of patients while they had an ORBERA, which is an incident rate of less than one one-hundredth of one percent of the more than 277,000 ORBERA balloons distributed in the same time period. Since receiving FDA approval in August 2015, the incident rate remains less than 0.01%. ORBERA remains the only intragastric balloon that meets the American Society of Gastrointestinal Endoscopy's, or ASGE, threshold standards for the treatment of obesity. Todd Newton, CEO of Apollo states: "Patient safety is a key priority in everything we do at Apollo Endosurgery and we take adverse event reporting obligations related to our products very seriously. The FDA letter is an important reminder to the physician community that obesity is a serious disease and many obese patients are affected by one or more co-morbid conditions due to their obesity. In our physician training, we are diligent to emphasize the factors that support the safe and effective use of ORBERA and we will continue to do so."

APEN Apollo Endosurgery
$4.20

-1.46 (-25.80%)

07/24/17
CHLM
07/24/17
INITIATION
Target $11
CHLM
Buy
Apollo Endosurgery initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Matt Hewitt started Apollo Endosurgery initiated with a Buy rating and $11, citing the opportunity he sees in its portfolio of three therapies to treat obesity. One of those three, OverStitch, is a "lottery ticket" that could quadruple the stock if it were to receive reimbursement, Hewitt added.
08/02/17
ROTH
08/02/17
INITIATION
Target $10
ROTH
Buy
Apollo Endosurgery initiated with a Buy at Roth Capital
Roth Capital analyst Chris Lewis started Apollo Endosurgery with a Buy rating and a $10 price target as he believes Apollo is an attractive "masked growth" Med Tech company with long-term growth potential driven by continued strong Endo-Bariatric segment growth, from both Orbera and OverStitch, paired with moderating declines in its Lap-Band Surgical business.

TODAY'S FREE FLY STORIES

PACW

PacWest Bancorp

$44.13

-1.63 (-3.56%)

, CUNB

CU Bancorp

$35.10

-0.6 (-1.68%)

14:27
08/18/17
08/18
14:27
08/18/17
14:27
Conference/Events
CU Bancorp to host special shareholder meeting »

Special Shareholder…

PACW

PacWest Bancorp

$44.13

-1.63 (-3.56%)

CUNB

CU Bancorp

$35.10

-0.6 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UEC

Uranium Energy

$1.34

0.0086 (0.65%)

14:27
08/18/17
08/18
14:27
08/18/17
14:27
Hot Stocks
Breaking Hot Stocks news story on Uranium Energy »

Pacific Road reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXL

American Axle

$13.99

-0.03 (-0.21%)

14:25
08/18/17
08/18
14:25
08/18/17
14:25
Options
American Axle call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$16.11

-0.82 (-4.84%)

14:23
08/18/17
08/18
14:23
08/18/17
14:23
Earnings
Breaking Earnings news story on MiMedx »

MiMedx backs FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

RPM

RPM

$48.24

-0.58 (-1.19%)

14:21
08/18/17
08/18
14:21
08/18/17
14:21
Upgrade
RPM rating change  »

RPM upgraded to Gradually…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$16.11

-0.82 (-4.84%)

14:21
08/18/17
08/18
14:21
08/18/17
14:21
Hot Stocks
MiMedx in pact to divest Stability Biologics, focus on biopharma »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

$NSD

NASDAQ Market Internals

14:17
08/18/17
08/18
14:17
08/18/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
08/18/17
08/18
14:16
08/18/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRBT

iRobot

$98.82

-3.55 (-3.47%)

14:12
08/18/17
08/18
14:12
08/18/17
14:12
Periodicals
Spruce Point questions iRobot's financial guidance »

Spruce Point Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$16.11

-0.82 (-4.84%)

14:11
08/18/17
08/18
14:11
08/18/17
14:11
Hot Stocks
Breaking Hot Stocks news story on MiMedx »

MiMedx in pact to divest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

GE

General Electric

$24.62

-0.1264 (-0.51%)

14:00
08/18/17
08/18
14:00
08/18/17
14:00
Options
19K GE Oct 27 - Jan 27 call spreads at 20c on ISE »

19K GE Oct 27 - Jan 27…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 02

    Oct

RTNB

root9B Technologies

$0.60

-0.1665 (-21.72%)

14:00
08/18/17
08/18
14:00
08/18/17
14:00
Hot Stocks
Breaking Hot Stocks news story on root9B Technologies »

root9B Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MATX

Matson

$22.53

-6.8159 (-23.22%)

13:56
08/18/17
08/18
13:56
08/18/17
13:56
Hot Stocks
Matson drops after competitor TOTE enters Hawaii trade route »

Matson (MATX), which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$243.52

0.4256 (0.18%)

, SPX

S&P 500

13:51
08/18/17
08/18
13:51
08/18/17
13:51
Periodicals
Breitbart's Pollak tweets '#WAR', after Steve Bannon departs White House »

Senior-editor-at-large…

SPY

SPDR S&P 500 ETF Trust

$243.52

0.4256 (0.18%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$17.68

-0.115 (-0.65%)

13:50
08/18/17
08/18
13:50
08/18/17
13:50
Options
Short-term call buyers in KeyCorp »

Short-term call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

FB

Facebook

$166.91

-3.09 (-1.82%)

13:46
08/18/17
08/18
13:46
08/18/17
13:46
Hot Stocks
Facebook's Zuckerberg says plans to take two months of paternity leave »

Facebook's Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

  • 13

    Sep

AMC

AMC Entertainment

$12.53

-0.625 (-4.75%)

13:45
08/18/17
08/18
13:45
08/18/17
13:45
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 14

    Sep

  • 27

    Sep

TEVA

Teva

$17.21

0.11 (0.64%)

13:40
08/18/17
08/18
13:40
08/18/17
13:40
Hot Stocks
Teva announces exclusive launch of generic Axiron in the U.S. »

Teva announced the launch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

LGF.A

Lionsgate

$28.25

0.21 (0.75%)

, LGF.B

Lionsgate

$27.18

0.175 (0.65%)

13:37
08/18/17
08/18
13:37
08/18/17
13:37
Hot Stocks
Box Office Battle: 'Annabelle: Creation' to remain in first place »

The major film release…

LGF.A

Lionsgate

$28.25

0.21 (0.75%)

LGF.B

Lionsgate

$27.18

0.175 (0.65%)

TWX

Time Warner

$101.58

-0.03 (-0.03%)

DIS

Disney

$101.02

-0.36 (-0.36%)

VIA

Viacom

$42.40

1.75 (4.31%)

VIAB

Viacom

$29.21

-0.61 (-2.05%)

FOX

21st Century Fox

$26.89

-0.67 (-2.43%)

FOXA

21st Century Fox

$27.35

-0.64 (-2.29%)

SNE

Sony

$38.85

-0.15 (-0.38%)

CMCSA

Comcast

$40.27

-0.97 (-2.35%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 27

    Sep

  • 29

    Sep

MATX

Matson

$22.40

-6.9536 (-23.69%)

13:29
08/18/17
08/18
13:29
08/18/17
13:29
Upgrade
Matson rating change  »

Matson upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYV

Live Nation

$39.06

0.02 (0.05%)

, FB

Facebook

$166.91

-3.09 (-1.82%)

13:28
08/18/17
08/18
13:28
08/18/17
13:28
Hot Stocks
Live Nation drops sharply after Facebook adding ticket sales »

Shares of Live Nation…

LYV

Live Nation

$39.06

0.02 (0.05%)

FB

Facebook

$166.91

-3.09 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 22

    Aug

  • 24

    Aug

  • 13

    Sep

BZUN

Baozun

$33.50

-1.98 (-5.58%)

13:25
08/18/17
08/18
13:25
08/18/17
13:25
Options
Baozun call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

FB

Facebook

$166.91

-3.09 (-1.82%)

, EBAY

eBay

$34.85

-0.51 (-1.44%)

13:20
08/18/17
08/18
13:20
08/18/17
13:20
Periodicals
Facebook adding ticket sales to Marketplace, Recode reports »

Facebook's (FB)…

FB

Facebook

$166.91

-3.09 (-1.82%)

EBAY

eBay

$34.85

-0.51 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

  • 28

    Aug

  • 29

    Aug

  • 07

    Sep

  • 13

    Sep

PEI

Pennsylvania REIT

$10.11

-0.28 (-2.69%)

, FL

Foot Locker

$34.98

-12.72 (-26.67%)

13:18
08/18/17
08/18
13:18
08/18/17
13:18
Periodicals
Pennsylvania REIT falls after Foot Locker weakness, Bloomberg says »

Shares of Pennsylvania…

PEI

Pennsylvania REIT

$10.11

-0.28 (-2.69%)

FL

Foot Locker

$34.98

-12.72 (-26.67%)

LB

L Brands

$36.28

-1.27 (-3.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

SPX

S&P 500

13:17
08/18/17
08/18
13:17
08/18/17
13:17
Hot Stocks
WH Press Sec.: Kelly, Bannon 'mutually agreed today would be Steve's last day' »

A statement from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.